If youre currently on a GLP-1 medication and experiencing hair thinning, our team can help you determine the right strategy for your individual needs
Why Relapse Happens After Discontinuation of GLP-1 Agonists The core issue is that obesity is a chronic, relapsing disease, not a temporary condition like a bacterial infection

Cholelithiasis (gallstones) was reported at low rates in the Phase 2 trial Incidence was slightly higher in higher-dose groups, though absolute numbers were small This observation is not unique to retatrutide semaglutide and tirzepatide trials also reported gallbladder events Cardiovascular Observations Heart rate changes were documented in clinical trial participants: Small mean increases in heart rate (2-4 bpm) were observed in active treatment groups This is consistent with GLP-1 agonist class effects semaglutide and tirzepatide produce similar heart rate increases No increased rate of major adverse cardiovascular events (MACE) was observed in Phase 2 TRIUMPH-4 is specifically designed to evaluate cardiovascular outcomes at scale Injection Site Reactions As a subcutaneous injectable, injection site reactions were reported: Injection site erythema, pain, and pruritus were documented at low rates Most injection site events were Grade 1 (mild) No injection site reactions led to treatment discontinuation in published data How Retatrutide Adverse Events Compare to Other GLP-1 Compounds Comparing adverse event profiles across different trials has significant limitations patient populations, dose ranges, and endpoint definitions vary

At what dose is Compounded Semaglutide typically prescribed
CrossRef Exploration and optimization of indole derivatives as novel anti-HBV agent with potential TLR7-agonistic effect Lihua Yang, Zibin Qiu, Xincheng Li, Jiachen Wei, Yike Ma, Weiqun Yuan, Qiuting Xu, Xiaoke Gu, Jingying Qiu Bioorganic & Medicinal Chemistry .2026
Client Experiences I started GHK-Cu peptide therapy at MedLounge San Ramon because I was noticing thinning skin and early hair density changes